246 related articles for article (PubMed ID: 24086346)
21. Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications.
Deng Q; Tang DG
Endocr Relat Cancer; 2015 Dec; 22(6):T209-20. PubMed ID: 26285606
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells.
Huss WJ; Gray DR; Greenberg NM; Mohler JL; Smith GJ
Cancer Res; 2005 Aug; 65(15):6640-50. PubMed ID: 16061644
[TBL] [Abstract][Full Text] [Related]
23. Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer.
Timofeeva OA; Palechor-Ceron N; Li G; Yuan H; Krawczyk E; Zhong X; Liu G; Upadhyay G; Dakic A; Yu S; Fang S; Choudhury S; Zhang X; Ju A; Lee MS; Dan HC; Ji Y; Hou Y; Zheng YL; Albanese C; Rhim J; Schlegel R; Dritschilo A; Liu X
Oncotarget; 2017 Apr; 8(14):22741-22758. PubMed ID: 28009986
[TBL] [Abstract][Full Text] [Related]
24. Conditionally Reprogrammed Cells from Patient-Derived Xenograft to Model Neuroendocrine Prostate Cancer Development.
Ci X; Hao J; Dong X; Xue H; Wu R; Choi SYC; Haegert AM; Collins CC; Liu X; Lin D; Wang Y
Cells; 2020 Jun; 9(6):. PubMed ID: 32512818
[TBL] [Abstract][Full Text] [Related]
25. Primary prostate cancer cultures are models for androgen-independent transit amplifying cells.
Bühler P; Wolf P; Katzenwadel A; Schultze-Seemann W; Wetterauer U; Freudenberg N; Elsässer-Beile U
Oncol Rep; 2010 Feb; 23(2):465-70. PubMed ID: 20043108
[TBL] [Abstract][Full Text] [Related]
26. A convenient and effective strategy for the enrichment of tumor-initiating cell properties in prostate cancer cells.
Zhang Y; Huang Y; Jin Z; Li X; Li B; Xu P; Huang P; Liu C
Tumour Biol; 2016 Sep; 37(9):11973-11981. PubMed ID: 27113741
[TBL] [Abstract][Full Text] [Related]
27. The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.
Qin J; Liu X; Laffin B; Chen X; Choy G; Jeter CR; Calhoun-Davis T; Li H; Palapattu GS; Pang S; Lin K; Huang J; Ivanov I; Li W; Suraneni MV; Tang DG
Cell Stem Cell; 2012 May; 10(5):556-69. PubMed ID: 22560078
[TBL] [Abstract][Full Text] [Related]
28. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan.
Emmink BL; Van Houdt WJ; Vries RG; Hoogwater FJ; Govaert KM; Verheem A; Nijkamp MW; Steller EJ; Jimenez CR; Clevers H; Borel Rinkes IH; Kranenburg O
Gastroenterology; 2011 Jul; 141(1):269-78. PubMed ID: 21459094
[TBL] [Abstract][Full Text] [Related]
29. TMPRSS2/ERG fusion gene expression alters chemo- and radio-responsiveness in cell culture models of androgen independent prostate cancer.
Swanson TA; Krueger SA; Galoforo S; Thibodeau BJ; Martinez AA; Wilson GD; Marples B
Prostate; 2011 Oct; 71(14):1548-58. PubMed ID: 21394739
[TBL] [Abstract][Full Text] [Related]
30. Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer.
Kregel S; Kiriluk KJ; Rosen AM; Cai Y; Reyes EE; Otto KB; Tom W; Paner GP; Szmulewitz RZ; Vander Griend DJ
PLoS One; 2013; 8(1):e53701. PubMed ID: 23326489
[TBL] [Abstract][Full Text] [Related]
31. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
[TBL] [Abstract][Full Text] [Related]
32. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
[TBL] [Abstract][Full Text] [Related]
33. Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer.
Carpentino JE; Hynes MJ; Appelman HD; Zheng T; Steindler DA; Scott EW; Huang EH
Cancer Res; 2009 Oct; 69(20):8208-15. PubMed ID: 19808966
[TBL] [Abstract][Full Text] [Related]
34. Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.
Chuu CP; Kokontis JM; Hiipakka RA; Fukuchi J; Lin HP; Lin CY; Huo C; Su LC; Liao S
Cancer Sci; 2011 Nov; 102(11):2022-8. PubMed ID: 21781227
[TBL] [Abstract][Full Text] [Related]
35. Functional characteristics of cancer stem cells and their role in drug resistance of prostate cancer.
Castillo V; Valenzuela R; Huidobro C; Contreras HR; Castellon EA
Int J Oncol; 2014 Sep; 45(3):985-94. PubMed ID: 24990514
[TBL] [Abstract][Full Text] [Related]
36. Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesion.
Bansal N; Davis S; Tereshchenko I; Budak-Alpdogan T; Zhong H; Stein MN; Kim IY; Dipaola RS; Bertino JR; Sabaawy HE
Prostate; 2014 Feb; 74(2):187-200. PubMed ID: 24154958
[TBL] [Abstract][Full Text] [Related]
37. Prostate cancer stem cells: do they have a basal or luminal phenotype?
Maitland NJ; Frame FM; Polson ES; Lewis JL; Collins AT
Horm Cancer; 2011 Feb; 2(1):47-61. PubMed ID: 21761340
[TBL] [Abstract][Full Text] [Related]
38. Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer.
Wang Z; Wu D; Ng CF; Teoh JY; Yu S; Wang Y; Chan FL
Endocr Relat Cancer; 2018 Jan; 25(1):35-50. PubMed ID: 29042395
[TBL] [Abstract][Full Text] [Related]
39. Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells.
Jiao J; Hindoyan A; Wang S; Tran LM; Goldstein AS; Lawson D; Chen D; Li Y; Guo C; Zhang B; Fazli L; Gleave M; Witte ON; Garraway IP; Wu H
PLoS One; 2012; 7(8):e42564. PubMed ID: 22880034
[TBL] [Abstract][Full Text] [Related]
40. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-sensitive LNCaP cells.
Yuan TC; Veeramani S; Lin FF; Kondrikou D; Zelivianski S; Igawa T; Karan D; Batra SK; Lin MF
Endocr Relat Cancer; 2006 Mar; 13(1):151-67. PubMed ID: 16601285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
